ANI Pharmaceuticals Inc (ANIP)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -18,522 | 18,779 | -47,896 | -42,603 | -22,548 |
| Revenue | US$ in thousands | 614,376 | 486,816 | 316,385 | 216,136 | 208,475 |
| Net profit margin | -3.01% | 3.86% | -15.14% | -19.71% | -10.82% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $-18,522K ÷ $614,376K
= -3.01%
The net profit margin of ANI Pharmaceuticals Inc has shown fluctuations over the years based on the provided data. In December 31, 2020, the company had a net profit margin of -10.82%, indicating that the company's expenses exceeded its revenue, resulting in a loss. This negative trend worsened in December 31, 2021, with a net profit margin of -19.71%, highlighting further financial challenges.
However, there was a significant improvement by December 31, 2023, where the net profit margin turned positive at 3.86%, suggesting that the company generated a profit relative to its revenue. This positive momentum was not sustained, as by December 31, 2024, the net profit margin decreased to -3.01%, reflecting a decrease in profitability.
Overall, ANI Pharmaceuticals Inc has experienced fluctuations in net profit margin over the years, indicating varying levels of profitability and financial performance. It is important for the company to closely monitor its expenses and revenue generation strategies to ensure sustained profitability in the future.
Peer comparison
Dec 31, 2024